[1] World Health Organization. Born too soon: the global action report on preterm birth[EB].(2012)[2022-05-01]. https://apps.who.int/iris/bitstream/handle/10665/44864/9789241503433_eng.pdf?sequence=1&isAllowed=y.
[2] Mwaniki MK, Atieno M, Lawn JE, et al. Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review[J]. Lancet, 2012,379(9814):445-452. DOI: 10.1016/S0140-6736(11)61577-8.
[3] Magee LA, De Silva DA, Sawchuck D, et al. No. 376-Magnesium sulphate for fetal neuroprotection[J]. J Obstet Gynaecol Can, 2019,41(4):505-522. DOI: 10.1016/j.jogc.2018. 09.018.
[4] 中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2020)[J].中华妇产科杂志,2020,55(4):227-238. DOI: 10.3760/cma.j.cn112141-20200114-00039.
Hypertensive Disorders in Pregnancy Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association. Diagnosis and treatment of hypertension and pre-eclampsia in pregnancy: a clinical practice guideline in China(2020)[J]. Chin J Obstet Gynecol, 2020,55(4):227-238. DOI: 10.3760/cma.j.cn112141-20200114-00039.
[5] Marret S, Gressens P, Gadisseux JF, et al. Prevention by magnesium of excitotoxic neuronal death in the developing brain: an animal model for clinical intervention studies[J]. Dev Med Child Neurol, 1995,37(6):473-484. DOI: 10.1111/j.1469-8749.1995.tb12035.x.
[6] Mittendorf R, Covert R, Boman J, et al. Is tocolytic magnesium sulphate associated with increased total paediatric mortality?[J]. Lancet, 1997,350(9090):1517-1518. DOI: 10.1016/s0140- 6736(97)24047-x.
[7] Crowther CA, Hiller JE, Doyle LW, et al. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial[J]. JAMA, 2003,290(20):2669-2676. DOI: 10.1001/jama.290.20.2669.
[8] Marret S, Marpeau L, Zupan-Simunek V, et al. Magnesium sulphate given before very-preterm birth to protect infant brain: the randomised controlled PREMAG trial*[J]. BJOG, 2007,114(3):310-318. DOI: 10.1111/j.1471-0528.2006.01162.x.
[9] Marret S, Marpeau L, Bénichou J. Benefit of magnesium sulfate given before very preterm birth to protect infant brain[J]. Pediatrics, 2008,121(1):225-226. DOI: 10.1542/peds.2007-2971.
[10] Mittendorf R, Dambrosia J, Pryde PG, et al. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants[J]. Am J Obstet Gynecol, 2002,186(6):1111-1118. DOI: 10.1067/mob.2002.123544.
[11] Rouse DJ, Hirtz DG, Thom E, et al. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy[J]. N Engl J Med, 2008,359(9):895-905. DOI: 10.1056/NEJMoa0801187.
[12] Magpie Trial Follow-Up Study Collaborative Group. The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months[J]. BJOG, 2007,114(3):289-299. DOI: 10.1111/j. 1471- 0528.2006.01165.x.
[13] Conde-Agudelo A, Romero R. Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and metaanalysis[J]. Am J Obstet Gynecol, 2009,200(6):595-609. DOI: 10.1016/j.ajog. 2009.04.005.
[14] 中华医学会妇产科学分会产科学组.早产临床诊断与治疗指南(2014)[J].中华围产医学杂志,2015,18(4):241-245.DOI:10.3760/cma.j.issn.1007-9408.2015.04.01.
Obstetrics Subgroup, Society of Obstetrics and Gynecology, Chinese Medical Association. Guidelines for clinical diagnosis and treatment of preterm birth (2014) [J]. Chin J Perinat Med, 2015,18(4):241-245.DOI:10.3760/cma.j.issn. 1007-9408.2015. 04.01.
[15] Reeves SA, Gibbs RS, Clark SL. Magnesium for fetal neuroprotection[J]. Am J Obstet Gynecol, 2011,204(3):202.e1-4. DOI: 10.1016/j.ajog.2011.01.014.
[16] National Institute for Health and Care Excellence. Preterm labour and birth[EB/OL].(2015)[2022-05-01].https://www.nice.org.uk/guidance/ng25/evidence/full-guideline-pdf-2176838029.
[17] Cahill AG, Odibo AO, Stout MJ, et al. Magnesium sulfate therapy for the prevention of cerebral palsy in preterm infants: a decision-analytic and economic analysis[J]. Am J Obstet Gynecol, 2011,205(6):542.e1-7. DOI: 10.1016/j.ajog.2011. 09.004.
[18] Crowther CA, Middleton PF, Voysey M, et al. Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: An individual participant data meta-analysis[J]. PLoS Med, 2017,14(10):e1002398. DOI: 10.1371/journal.pmed. 1002398.
[19] Crowther CA, Middleton PF, Wilkinson D, et al. Magnesium sulphate at 30 to 34 weeks' gestational age: neuroprotection trial (MAGENTA)--study protocol[J]. BMC Pregnancy Childbirth, 2013,13:91. DOI: 10.1186/1471-2393-13-91.
[20] Antenatal Magnesium Sulfate for Neuroprotection Guideline Development Panel. Antenatal magnesium sulphate prior to preterm birth for neuroprotection of the fetus, infant and child: National clinical practice guidelines [EB/OL].(2020-11-17)[2022-05-01].https://cdn.auckland.ac.nz/assets/liggins/docs/Antenatal%20magnesium%20sulphate%20prior%20to%20 preterm%20birth%20for%20neuroprotection%20of%20the%20fetus,%20infant%20&%20child,%20National%20clinical%20 practice%20guidelines.pdf.
[21] Institute of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland; Directorate of Strategy and Clinical Care Health Service Executive. Clinical practice guidelines. Antenatal magnesium sulfate for fetal neuroprotection[EB/OL]. (2015-04)[2022-05-01]. https://www.hse.ie/eng/services/publications/clini- cal-strategy-and-programmes / antenatal-magnesium-sulphate-for- fetal-neuroprotection.pdf.
[22] Roelens K, Roberfroid D, Ahmadzai N, et. al. Prevention of preterm birth in women at risk: selected topics[EB/OL].(2014) [2022-05-01]. https://www.researchgate.net/publication/293652054_PREVENTION_OF_PRETERM_BIRTH_IN_WOMEN_AT_RISK_SELECTED_TOPICS?channel=doi&linkId=56ba296a08ae6a0040addd28&showFulltext=true.
[23] Sentilhes L, Sénat MV, Ancel PY, et al. Prevention of spontaneous preterm birth: Guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF)[J]. Eur J Obstet Gynecol Reprod Biol, 2017,210:217- 224. DOI: 10.1016/j.ejogrb.2016.12.035.
[24] Cuff RD, Sullivan SA, Chang EY. Impact of dosing schedule on uptake of neuroprotective magnesium sulfate[J]. J Matern Fetal Neonatal Med, 2020,33(6):982-986. DOI: 10.1080/14767058. 2018.1513482.
[25] Bain ES, Middleton PF, Crowther CA. Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review[J]. BMC Pregnancy Childbirth, 2013,13:195. DOI: 10.1186/1471- 2393-13-195.
[26] Malapaka SV, Ballal PK. Low-dose magnesium sulfate versus Pritchard regimen for the treatment of eclampsia imminent eclampsia[J]. Int J Gynaecol Obstet, 2011,115(1):70-72. DOI: 10.1016/j.ijgo.2011.05.013.
[27] Vilchez G, Dai J, Lagos M, et al. Maternal side effects & fetal neuroprotection according to body mass index after magnesium sulfate in a multicenter randomized controlled trial[J]. J Matern Fetal Neonatal Med, 2018,31(2):178-183. DOI: 10.1080/14767058.2017.1279143.
[28] US Food and Drug Administration. Drug Safety Communications. FDA recommends against prolonged use of magnesium sulfate to stop pre-term labor due to bone changes in exposed babies [EB/OL].(2014-02-05)[2022-05-01]. https://www.fda.gov/media/85971/download.
[29] Shepherd E, Salam RA, Manhas D, et al. Antenatal magnesium sulphate and adverse neonatal outcomes: A systematic review and meta-analysis[J]. PLoS Med, 2019,16(12):e1002988. DOI: 10.1371/journal.pmed.1002988.
[30] Committee Opinion No. 455: Magnesium sulfate before anticipated preterm birth for neuroprotection[J]. Obstet Gynecol, 2010,115(3):669-671. DOI: 10.1097/AOG.0b013e3181d4ffa5.
[31] Sela HY, Simpson LL. Preterm premature rupture of membranes complicating twin pregnancy: management considerations[J]. Clin Obstet Gynecol, 2011,54(2):321-329. DOI: 10.1097/GRF. 0b013e318217d60d.
[32] Stockley EL, Ting JY, Kingdom JC, et al. Intrapartum magnesium sulfate is associated with neuroprotection in growth-restricted fetuses[J]. Am J Obstet Gynecol, 2018,219(6):606.e1-606.e8. DOI: 10.1016/j.ajog.2018.09.010.
[33] 中华医学会围产医学分会胎儿医学学组,中华医学会妇产科学分会产科学组. 胎儿生长受限专家共识(2019版)[J]. 中华围产医学杂志,2019,22(6):361-380. DOI:10.3760/cma.j.issn.1007- 9408.2019.06.001.
Fetal Medicine Subgroup, Society of Perintal Medicine, Chinese Medical Association;Obstetrics Subgroup, Society of Obstetrics and Gynecology, Chinese Medical Association. Expert consensus on fetal growth restriction[J].Chin J Perinat Med,2019,22(6):361-380. DOI:10.3760/cma.j.issn.1007-9408.2019.06.001.
[34] Garg BD. Antenatal magnesium sulfate is beneficial or harmful in very preterm and extremely preterm neonates: a new insight[J]. J Matern Fetal Neonatal Med, 2019,32(12):2084-2090. DOI: 10.1080/14767058.2018.1424823.
[35] Doyle LW, Crowther CA, Middleton P, et al. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus[J]. Cochrane Database Syst Rev, 2009,(1):CD004661. DOI: 10.1002/14651858.CD004661.pub3.
[36] Crowther CA, Brown J, McKinlay CJ, et al. Magnesium sulphate for preventing preterm birth in threatened preterm labour[J]. Cochrane Database Syst Rev, 2014,(8):CD001060. DOI: 10.1002/14651858.CD001060.pub2.